BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21901940)

  • 1. Genotype-phenotype diversity of beta-thalassemia in Malaysia: treatment options and emerging therapies.
    George E; Ann TJ
    Med J Malaysia; 2010 Dec; 65(4):256-60. PubMed ID: 21901940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-thalassemia major in Malaysia, an ongoing public health problem.
    George E
    Med J Malaysia; 2001 Dec; 56(4):397-400. PubMed ID: 12014756
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterisation of beta-globin gene mutations in Malaysian children: a strategy for the control of beta-thalassaemia in a developing country.
    Thong MK; Tan JA; Tan KL; Yap SF
    J Trop Pediatr; 2005 Dec; 51(6):328-33. PubMed ID: 15967770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of transfusion dependent beta-thalassemia major patients in Sabah.
    Teh LK; George E; Lai MI; Tan JA; Wong L; Ismail P
    J Hum Genet; 2014 Mar; 59(3):119-23. PubMed ID: 24369358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic modifiers of beta-thalassemia.
    Thein SL
    Haematologica; 2005 May; 90(5):649-60. PubMed ID: 15921380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
    Malik P; Arumugam PI; Yee JK; Puthenveetil G
    Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of beta globin gene mutations on the clinical phenotype of beta thalassemia in India.
    Colah R; Nadkarni A; Gorakshakar A; Phanasgaonkar S; Surve R; Subramaniam PG; Bondge N; Pujari K; Ghosh K; Mohanty D
    Blood Cells Mol Dis; 2004; 33(2):153-7. PubMed ID: 15315795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of concurrent alpha-thalassaemia 1 in beta-thalassaemia carriers.
    Chong YM; Tan JA; Zubaidah Z; Rahimah A; Kuldip K; George E
    Med J Malaysia; 2006 Jun; 61(2):217-20. PubMed ID: 16898315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and therapy for haemoglobinopathies. Part II: thalassaemias.
    Urbinati F; Madigan C; Malik P
    Expert Rev Mol Med; 2006 May; 8(10):1-26. PubMed ID: 16684395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta(o)/beta(o) thalassemia with a mild phenotype].
    Hémar C; Nibourel O; Maboudou P; Méreau-Richard C; Badens C; Rousseaux J; Rose C
    Ann Biol Clin (Paris); 2006; 64(4):341-5. PubMed ID: 16829478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of beta-globin gene mutations in children with beta-thalassaemia major from Kota Kinabalu, Sabah, Malaysia.
    Thong MK; Soo TL
    Singapore Med J; 2005 Jul; 46(7):340-3. PubMed ID: 15968446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular pathology of beta-thalassemia in Turkey: the Boğaziçi university experience.
    Basak AN
    Hemoglobin; 2007; 31(2):233-41. PubMed ID: 17486506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-inherited Gilbert's syndrome: a factor determining hyperbilirubinemia in homozygous beta-thalassemia.
    Galanello R; Cipollina MD; Dessì C; Giagu N; Lai E; Cao A
    Haematologica; 1999 Feb; 84(2):103-5. PubMed ID: 10091405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta-thalassemia: clinical manifestations].
    Perrimond H
    Bull Soc Pathol Exot; 2001 May; 94(2):92-4. PubMed ID: 11475035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a national beta-thalassemia carrier screening program on the birth rate of thalassemia major.
    Chern JP; Lin KH; Su YN; Lu MY; Jou ST; Lin DT; Wang SC; Lin KS
    Pediatr Blood Cancer; 2006 Jan; 46(1):72-6. PubMed ID: 16206199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hb E beta +-thalassaemia in west Malaysia: clinical features in the most common beta-thalassaemia mutation of the Malays [IVS 1-5 (G-->C)].
    George E; Wong HB
    Singapore Med J; 1993 Dec; 34(6):500-3. PubMed ID: 8153710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal management of β thalassaemia intermedia.
    Taher AT; Musallam KM; Cappellini MD; Weatherall DJ
    Br J Haematol; 2011 Mar; 152(5):512-23. PubMed ID: 21250971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association of G779A ZHX-2 gene variant with HbF levels in β-thalassemia major.
    Munshi A; Dadheech S; Jain S; Joseph J; Al-Hazzani A; Alshatwi AA; Sai Babu M; Rajeshwar K; Jyothy A
    Eur J Haematol; 2011 Jun; 86(6):502-6. PubMed ID: 21443521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical severity of beta-thalassemia mutations in West Malaysia.
    George E
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():225-8. PubMed ID: 8629111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of beta-globin gene mutations among Kelantan Malay thalassaemia patients by polymerase chain reaction restriction fragment length polymorphism.
    Rozitah R; Nizam MZ; Nur Shafawati AR; Nor Atifah MA; Dewi M; Kannan TP; Ariffin N; Norsarwany M; Setianingsih I; Harahap A; Zilfalil BA
    Singapore Med J; 2008 Dec; 49(12):1046-9. PubMed ID: 19122960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.